News | August 16, 2022
QIAGEN launches syndromic test for QIAstat-Dx device to combat Monkeypox health emergency
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
The company has reported total income of Rs. 70.59 crores during the period ended June 30, 2022.
Meclizine Hydrochloride Tablets had estimated annual sales of USD 29 million in the U.S.
The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
Quetiapine Extended-Release Tablets are indicated for the treatment of Schizophrenia, Bipolar disorder and adjunctive treatment of Major Depressive Disorder (MDD)
ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
Man lost 54 Kgs in 6 months with MGB procedure
The company has reported total income of Rs. 403.38 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 65.19 crores during the period ended June 30, 2022.
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
Subscribe To Our Newsletter & Stay Updated
